Cytisinicline (Cytisine)

Cytisine is now a licensed prescription only medication in the UK. Note: we use the name Cytisine as opposed to Cytisinicline but you may need to use 'cytisinicline' if looking for the medication in the British National Formulary, and GPs will certainly need to use it to prescribe electronically as it will be listed as this.

This short film summarises what cytisine offers and urges health and social care organisations to make it available to people who smoke. The film was part-funded by a grant provided by Consilient Health who had no influence or input into the content.

Consilient Health announced the availability of Cytisine from 22nd January 2024 and the NCSCT has written a briefing to help practitioners prepare for supporting their clients to quit using cytisine. We will continue to develop resources as we gain more experience and expertise in the use of cytisine. We are also updating our online and virtual training content to support practitioners to prescribe/recommend cytisine.

A recent update from NICE including cytisine in their smoking cessation guidelines [NG209] is available here.

In addition to the Cytisine Briefing below, we have also included the Cytisine Summary of Product Characteristics (SPC) and an NCSCT Cytisine summary and dosing guide (improved for March 2024).

Our colleagues from Greater Manchester have made an application to their Medicines Management Board to get cytisine on their ICB formulary. They have kindly allowed us to post it here as a resource.